Table 2 Clinicopathologic characteristics of patients with metastatic renal cell carcinoma.
Number of patient | Â | Â | 12 |
Age, yr, median (range) |  |  | 65 (40–80) |
Female/Male | Â | Â | 2/10 |
Tumor size, cm, mean ± SD |  |  | 7.6 ± 3.5 |
Radical nephrectomy/Biopsy | 7/5 | Â | Â |
Histology, n (%) | Clear cell | Â | 9 (75) |
| Â | Non-clear | Papillary | 2 (16.7) |
| Â | Â | Mucinous tubular spindle cell | 1 (8.3) |
| Â | *Lymph vascular invasion positive | Â | 7 (100) |
IMDC classification, n (%) | Good | 5 (41.7) | Â |
| Â | Â | Intermediate | 2 (16.7) |
| Â | Â | Poor | 5 (41.7) |
Metastatic lesions, n (%) | Lymph node | Â | 8 (66.7) |
| Â | Lung | Â | 8 (66.7) |
| Â | Bone | Â | 5 (41.7) |
| Â | Liver | Â | 5 (41.7) |
| Â | Adrenal gland | 1 (8.3) | Â |
| Â | Contralateral Kidney | 1 (8.3) | Â |
| Â | Spleen | Â | 1 (8.3) |
| Â | Pleural | Â | 1 (8.3) |
| Â | Salivary gland | 1 (8.3) | Â |
| Â | Parotid gland | 1 (8.3) | Â |
